EPISODE · Sep 4, 2026 · 5 MIN
Anvisa aprova novo medicamento para câncer de pâncreas com metástase
from Jornal da CBN · host CBN
Luis Fernando Correia destaca que a Anvisa aprovou o uso do irinotecano lipossomal peguilado como tratamento de primeira linha para câncer de pâncreas com metástases, ampliando as opções terapêuticas para pacientes com a doença. Learn more about your ad choices. Visit megaphone.fm/adchoices
Embed this episode
Ready to play
Anvisa aprova novo medicamento para câncer de pâncreas com metástase
0:00
5:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Jornal da CBN?
This episode is 5 minutes long.
When was this Jornal da CBN episode published?
This episode was published on September 4, 2026.
Can I download this Jornal da CBN episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!